Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
Microsoft
MSFT
|
+$695M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$529M |
| 3 |
Digital Realty Trust
DLR
|
+$504M |
| 4 |
Intuitive Surgical
ISRG
|
+$494M |
| 5 |
Amazon
AMZN
|
+$479M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$694M |
| 2 |
Palo Alto Networks
PANW
|
+$510M |
| 3 |
DexCom
DXCM
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$444M |
| 5 |
AT&T
T
|
+$403M |
Sector Composition
| 1 | Technology | 16.27% |
| 2 | Healthcare | 15.74% |
| 3 | Consumer Discretionary | 10.72% |
| 4 | Financials | 10.36% |
| 5 | Industrials | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3151
First Trust Global Tactical Commodity Strategy Fund
FTGC
$2.23B
| $773K | ﹤0.01% |
+33,939
| New | +$773K |
|
3152
Castle Biosciences
CSTL
$656M
| $772K | ﹤0.01% |
56,283
-604,673
| -91% | -$8.3M |
|
3153
First Trust Financials AlphaDEX Fund
FXO
$2.28B
| $772K | ﹤0.01% |
+20,481
| New | +$772K |
|
3154
iShares ESG Advanced MSCI EAFE ETF
DMXF
$844M
| $772K | ﹤0.01% |
+12,672
| New | +$772K |
|
|
FINV
3155
FinVolution Group
FINV
$1.99B
| $771K | ﹤0.01% |
167,678
-199,372
| -54% | -$917K |
|
3156
FT Vest US Equity Deep Buffer ETF August
DAUG
$352M
| $770K | ﹤0.01% |
22,614
+7,018
| +45% | +$239K |
|
3157
Innodata
INOD
$2.28B
| $769K | ﹤0.01% |
67,891
+22,508
| +50% | +$255K |
|
3158
Tiptree Inc
TIPT
$877M
| $769K | ﹤0.01% |
51,215
+29,546
| +136% | +$443K |
|
3159
CoreCard
CCRD
$215M
| $767K | ﹤0.01% |
30,246
-10,109
| -25% | -$256K |
|
3160
iShares Morningstar Growth ETF
ILCG
$3.04B
| $767K | ﹤0.01% |
12,303
-34,329
| -74% | -$2.14M |
|
3161
Ameris Bancorp
ABCB
$5.19B
| $767K | ﹤0.01% |
22,413
-27,000
| -55% | -$924K |
|
|
INDF
3162
DELISTED
Nifty India Financials ETF
INDF
| $765K | ﹤0.01% |
21,782
-52,416
| -71% | -$1.84M |
|
3163
Invesco S&P International Developed Momentum ETF
IDMO
$1.76B
| $765K | ﹤0.01% |
+23,157
| New | +$765K |
|
3164
Invesco KBW Bank ETF
KBWB
$5.06B
| $764K | ﹤0.01% |
18,614
-14,048
| -43% | -$577K |
|
|
AUROW
3165
Aurora Innovation Warrant
AUROW
$1.15B
| $759K | ﹤0.01% |
1,650,835
-1,144
| -0.1% | -$526 |
|
|
TVRD
3166
Tvardi Therapeutics, Inc. Common Stock
TVRD
$372M
| $759K | ﹤0.01% |
7,452
-5,953
| -44% | -$607K |
|
3167
Northwest Bancshares
NWBI
$1.86B
| $758K | ﹤0.01% |
71,550
-232,474
| -76% | -$2.46M |
|
3168
Takeda Pharmaceutical
TAK
$47.6B
| $758K | ﹤0.01% |
48,275
-7,741
| -14% | -$122K |
|
|
TWOU
3169
DELISTED
2U, Inc.
TWOU
| $758K | ﹤0.01% |
6,272
-33,742
| -84% | -$4.08M |
|
3170
Praxis Precision Medicines
PRAX
$961M
| $758K | ﹤0.01% |
43,947
+2,361
| +6% | +$40.7K |
|
3171
iShares Core S&P US Growth ETF
IUSG
$25.5B
| $758K | ﹤0.01% |
7,763
-10,595
| -58% | -$1.03M |
|
3172
iShares Floating Rate Bond ETF
FLOT
$8.99B
| $755K | ﹤0.01% |
14,854
-53,236
| -78% | -$2.71M |
|
3173
JPMorgan Short Duration Core Plus ETF
JSCP
$831M
| $753K | ﹤0.01% |
16,447
+5,735
| +54% | +$263K |
|
3174
FB Financial Corp
FBK
$2.9B
| $752K | ﹤0.01% |
26,827
+18,886
| +238% | +$530K |
|
3175
ClearPoint Neuro
CLPT
$322M
| $752K | ﹤0.01% |
103,914
+29,976
| +41% | +$217K |
|